Bioph Summit CHINA 2014
Time:June 27-27, 2014
Country&Region:Shanghai, Shanghai, China Mainland
Venue:Hall E3, June 27th, 9:00-11:45
Organizer:Shanghai UBM Sinoexpo International Exhibition Co., Ltd (UBM Sinoexpo)
|
Bioph Summit CHINA 2014
Module One: Alliance & Commercialization
Hall E3, June 27th, 9:00-11:45
|
|
8:30-9:00
|
Registration
|
|
9:00-9:05
|
Address from Chairman
|
|
9:05-9:35
|
Finding the Right Biopharmaceutical Candidate and Growing Your Product Pipeline
l Experiences and studies from leading pharmaceutical companies on launching biopharma products
l How to plan the investment and production accurately
l Scaling up the biopharmaceutical process by understanding of both "real world" and laboratory conditions
Dr. Joe Zhou, CEO, Genor BioPharma
|
|
9:35-10:05
|
New Drug Development Case Study: 5 Years, 30 Million RMB, 3 IND Applications
l Understanding the significance of developing biopharmaceuticals in China
l How to select the appropriate project and evaluate the risks
l Experience sharing from Jiangsu T-mab Biopharma: 3 IND applications with 30 million RMB within 5 years in China
Dr. Yanshan Huang, Senior Vice President, Ph.D, Jiangsu T-mab BioPharma
|
|
10:05-10:45
|
Break, Networking & Visiting Exhibition
|
|
10:45-11:15
|
Extending Product Lines of Vaccine through Enhancing International Cooperation
l Analyzing the current vaccine market in China and exploring where is the gap with global players
l Why it is so urgent to enhance international cooperation
l Case studies on several successful stories
l Illustrating key issues leading to great partnership
Dr. Wu Ke, President, Shanghai BravoBio Co., Ltd
|
|
11:15-11:45
|
The Latest R&D Development of New Targets of Antibody-Drugs
Dr. Hongtao Lu, Chief Scientific Officer, Zai Laboratory, Inc.
|
|
11:45
|
The End of Module One
|
|
Bioph Summit CHINA 2014
Module One: Alliance & Commercialization
Hall E3, June 27th, 9:00-11:45
|
|
8:30-9:00
|
Registration
|
|
9:00-9:05
|
Address from Chairman
|
|
9:05-9:35
|
Finding the Right Biopharmaceutical Candidate and Growing Your Product Pipeline
l Experiences and studies from leading pharmaceutical companies on launching biopharma products
l How to plan the investment and production accurately
l Scaling up the biopharmaceutical process by understanding of both "real world" and laboratory conditions
Dr. Joe Zhou, CEO, Genor BioPharma
|
|
9:35-10:05
|
New Drug Development Case Study: 5 Years, 30 Million RMB, 3 IND Applications
l Understanding the significance of developing biopharmaceuticals in China
l How to select the appropriate project and evaluate the risks
l Experience sharing from Jiangsu T-mab Biopharma: 3 IND applications with 30 million RMB within 5 years in China
Dr. Yanshan Huang, Senior Vice President, Ph.D, Jiangsu T-mab BioPharma
|
|
10:05-10:45
|
Break, Networking & Visiting Exhibition
|
|
10:45-11:15
|
Extending Product Lines of Vaccine through Enhancing International Cooperation
l Analyzing the current vaccine market in China and exploring where is the gap with global players
l Why it is so urgent to enhance international cooperation
l Case studies on several successful stories
l Illustrating key issues leading to great partnership
Dr. Wu Ke, President, Shanghai BravoBio Co., Ltd
|
|
11:15-11:45
|
The Latest R&D Development of New Targets of Antibody-Drugs
Dr. Hongtao Lu, Chief Scientific Officer, Zai Laboratory, Inc.
|
|
11:45
|
The End of Module One
|
Pharma Sources Insight January 2025
